Intratumor heterogeneity: nature and biological significance TS Gerashchenko, EV Denisov, NV Litviakov, MV Zavyalova, ... Biochemistry (Moscow) 78, 1201-1215, 2013 | 163* | 2013 |
Changing the expression vector of multidrug resistance genes is related to neoadjuvant chemotherapy response NV Litviakov, NV Cherdyntseva, MM Tsyganov, EV Denisov, EY Garbukov, ... Cancer chemotherapy and pharmacology, 1-11, 2012 | 86 | 2012 |
Tumor-associated macrophages in human breast cancer produce new monocyte attracting and pro-angiogenic factor YKL-39 indicative for increased metastasis after neoadjuvant … T Liu, I Larionova, N Litviakov, V Riabov, M Zavyalova, M Tsyganov, ... Oncoimmunology 7 (6), e1436922, 2018 | 68 | 2018 |
Natural and chemotherapy-induced clonal evolution of tumors MK Ibragimova, MM Tsyganov, NV Litviakov Biochemistry (Moscow) 82, 413-425, 2017 | 67* | 2017 |
Intratumoral morphological heterogeneity of breast cancer: neoadjuvant chemotherapy efficiency and multidrug resistance gene expression EV Denisov, NV Litviakov, MV Zavyalova, VM Perelmuter, SV Vtorushin, ... Scientific reports 4 (1), 4709, 2014 | 67 | 2014 |
Deletions of multidrug resistance gene loci in breast cancer leads to the down-regulation of its expression and predict tumor response to neoadjuvant chemotherapy NV Litviakov, NV Cherdyntseva, MM Tsyganov, EM Slonimskaya, ... Oncotarget 7 (7), 7829, 2016 | 60 | 2016 |
NF-kB as a potential prognostic marker and a candidate for targeted therapy of cancer KA Gaptulbarova, MM Tsyganov, AM Pevzner, MK Ibragimova, ... Experimental oncology 42 (4), 263-269, 2020 | 45 | 2020 |
Expression of M2 macrophage markers YKL-39 and CCL18 in breast cancer is associated with the effect of neoadjuvant chemotherapy N Litviakov, M Tsyganov, I Larionova, M Ibragimova, I Deryusheva, ... Cancer chemotherapy and pharmacology 82, 99-109, 2018 | 40 | 2018 |
Human papillomavirus and colorectal cancer MK Ibragimova, MM Tsyganov, NV Litviakov Medical Oncology 35 (11), 140, 2018 | 38 | 2018 |
Genome-wide methylotyping resolves breast cancer epigenetic heterogeneity and suggests novel therapeutic perspectives AS Tanas, VO Sigin, AI Kalinkin, NV Litviakov, EM Slonimskaya, ... Epigenomics 11 (6), 605-617, 2019 | 37 | 2019 |
Invasive and drug resistant expression profile of different morphological structures of breast tumors EV Denisov, MV Zavyalova, NV Litvyakov, MM Tsyganov, ... | 37 | 2015 |
Amplifications of stemness genes and the capacity of breast tumors for metastasis N Litviakov, M Ibragimova, M Tsyganov, P Kazantseva, I Deryusheva, ... Oncotarget 11 (21), 1988, 2020 | 30 | 2020 |
Human papillomavirus and lung cancer: an overview and a meta-analysis MM Tsyganov, AM Pevzner, MK Ibragimova, IV Deryusheva, NV Litviakov Journal of Cancer Research and Clinical Oncology 145, 1919-1937, 2019 | 29 | 2019 |
DNA methylation markers panel can improve prediction of response to neoadjuvant chemotherapy in luminal B breast cancer VO Sigin, AI Kalinkin, EB Kuznetsova, OA Simonova, GG Chesnokova, ... Scientific Reports 10 (1), 9239, 2020 | 25 | 2020 |
ОБОСНОВАНИЕ ИСПОЛЬЗОВАНИЯ ЭКСПРЕССИОННЫХ МАРКЁРОВ ДЛЯ ПЕРСОНАЛИЗАЦИИ ХИМИОТЕРАПИИ РАКА ЛЁГКОГО ММ ЦЫГАНОВ, ЕО РОДИОНОВ, СВ МИЛЛЕР, НВ ЛИТВЯКОВ АНТИБИОТИКИ И ХИМИОТЕРАПИЯ 60, 9-10, 2015 | 25* | 2015 |
HPV status and its genomic integration affect survival of patients with cervical cancer. M Ibragimova, M Tsyganov, O Shpileva, O Churuksaeva, V Bychkov, ... Neoplasma 65 (3), 441-448, 2018 | 21 | 2018 |
Search for potential gastric cancer markers using miRNA databases and gene expression analysis V Volkomorov, E Grigoryeva, G Krasnov, N Litviakov, M Tsyganov, ... Experimental oncology, 2013 | 21 | 2013 |
Экспрессия генов множественной лекарственной устойчивости и монорезистентности при немелкоклеточном раке легкого. ЕЛ Юмов, ММ Цыганов, СВ Миллер, НВ Литвяков Сибирский онкологический журнал, 100-101, 2013 | 20 | 2013 |
Abscopal effect in the radio and immunotherapy. AM Pevzner, MM Tsyganov, MK Ibragimova, NV Litvyakov Radiation Oncology Journal 39 (4), 247-253, 2021 | 17 | 2021 |
Вирус папилломы человека и злокачественные новообразования головы и шеи (обзор литературы) АМ Певзнер, ММ Цыганов, МК Ибрагимова, НВ Литвяков Опухоли головы и шеи 9 (2), 43-52, 2019 | 17 | 2019 |